Advanced Medical Solutions Group (LON:AMS – Get Rating)‘s stock had its “buy” rating reaffirmed by analysts at Berenberg Bank in a note issued to investors on Wednesday, MarketBeat Ratings reports. They currently have a GBX 310 ($3.78) price target on the stock. Berenberg Bank’s price target suggests a potential upside of 29.17% from the company’s previous close.
Advanced Medical Solutions Group Stock Performance
AMS stock opened at GBX 240 ($2.93) on Wednesday. The company has a quick ratio of 4.58, a current ratio of 5.65 and a debt-to-equity ratio of 4.28. The firm has a 50 day moving average of GBX 258.11 and a two-hundred day moving average of GBX 262.40. The company has a market capitalization of £520.58 million, a price-to-earnings ratio of 3,012.50, a P/E/G ratio of 2.77 and a beta of 0.60. Advanced Medical Solutions Group has a 12 month low of GBX 229 ($2.79) and a 12 month high of GBX 319.50 ($3.89).
About Advanced Medical Solutions Group
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.